Our purpose was to investigate genes and molecular mechanisms involved in patients with Leber congenital amaurosis (LCA) and to model this type of LCA for drug screening. Fibroblasts from two unrelated clinically identified patients with a yet undetermined gene mutation were reprogrammed to pluripotency by retroviral transduction. These human induced pluripotent stem cells (hiPSCs) were differentiated into neural stem cells (NSCs) that mimicked the neural tube stage and retinal pigmented epithelial (RPE) cells that could be targeted by the disease. A genome-wide transcriptome analysis was performed with Affymetrix Exon Array GeneChip®, comparing LCA-hiPSCs derivatives to controls. A genomic search for alteration in all genes known to be involved in LCA revealed a common polymorphism on the GUCY2D gene, referenced as the LCA type I (OMIM *600179 and #204000), but the causative gene remained unknown. The hiPSCs expressed the key pluripotency factors and formed embryoid bodies in vitro containing cells originating from all three germ layers. They were successfully differentiated into NSC and RPE cells. One gene, NNAT, was upregulated in LCA cell populations, and three genes were downregulated, GSTT1, TRIM61 and ZNF558, with potential correlates for molecular mechanisms of this type of LCA, in particular for protein degradation and oxidative stress. The two LCA patient-specific iPSC lines will contribute to modeling LCA phenotypes and screening candidate drugs.
Get full access to this article
View all access options for this article.
References
1.
AclandG.M., AguirreG.D., RayJ., ZhangQ., AlemanT.S., CideciyanA.V., Pearce-KellingS.E., AnandV., ZengY., MaguireA.M., JacobsonS.G., HauswirthW.W., BennettJ.2001. Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet., 28:92–95.
2.
AguirreG.D., BaldwinV., Pearce-KellingS., NarfströmK., RayK., AclandG.M.1998. Congenital stationary night blindness in the dog: Common mutation in the RPE65 gene indicates founder effect. Mol. Vis., 4:23.
3.
AliR.R., SarraG.M., StephensC., AlwisM.D., BainbridgeJ.W., MunroP.M., FauserS., ReichelM.B., KinnonC., HuntD.M., BhattacharyaS.S., ThrasherA.J.2000. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat. Genet., 25:306–310.
4.
BaarsA.J., BreimerD.D.1980. The glutathione S-transferases: Their role in detoxification and toxification of xenobiotics. Ann. Biol. Clin. (Paris), 38:49–56.
BainbridgeJ.W.B., SmithA.J., BarkerS.S., RobbieS., HendersonR., BalagganK., ViswanathanA., HolderG.E., StockmanA., TylerN., Petersen-JonesS., BhattacharyaS.S., ThrasherA.J., FitzkeF.W., CarterB.J., RubinG.S., MooreA.T., AliR.R.2008. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med., 358:2231–2239.
7.
BanerjeeP., KleynP.W., KnowlesJ.A., LewisC.A., RossB.M., ParanoE., KovatsS.G., LeeJ.J., PenchaszadehG.K., OttJ., JacobsonS.G., GilliamT.C.1998. TULP1 mutation in two extended Dominican kindreds with autosomal recessive retinitis pigmentosa. Nat. Genet., 18:177–179.
8.
BattenM.L., ImanishiY., MaedaT., TuD.C., MoiseA.R., BronsonD., PossinD., Van GelderR.N., BaehrW., PalczewskiK.2004. Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. J. Biol. Chem., 279:10422–10432.
9.
CaiJ., NelsonK.C., WuM., SternbergP.Jr, JonesD.P.2000. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res., 19:205–221.
10.
ChambersS.M., FasanoC.A., PapapetrouE.P., TomishimaM., SadelainM., StuderL.2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol., 27:275–280.
11.
ChiangP.-W., WangJ., ChenY., FuQ., ZhongJ., ChenY., YiX., WuR., GanH., ShiY., ChenY., BarnettC., WheatonD., DayM., SutherlandJ., HeonE., WeleberR.G., GabrielL.A.R., CongP., ChuangK., YeS., SallumJ.M.F., QiM.2012. Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis. Nat. Genet., 44:972–974.
12.
ChunY.S., ByunK., LeeB.2011. Induced pluripotent stem cells and personalized medicine: Current progress and future perspectives. Anat. Cell Biol., 44:245–255.
13.
CideciyanA.V., AlemanT.S., BoyeS.L., SchwartzS.B., KaushalS., RomanA.J., PangJ.-j., SumarokaA., WindsorE.A.M., WilsonJ.M., FlotteT.R., FishmanG.A., HeonE., StoneE.M., ByrneB.J., JacobsonS.G., HauswirthW.W.2008. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc. Natl. Acad. Sci. USA, 105:15112–15117.
14.
ColmanA.2008. Induced pluripotent stem cells and human disease. Cell Stem Cell, 3:236–237.
15.
De la GrangeP., DutertreM., MartinN., AuboeufD.2005. FAST DB: A website resource for the study of the expression regulation of human gene products. Nucleic Acids Res., 33:4276–4284.
16.
De la GrangeP., DutertreM., CorreaM., AuboeufD.2007. A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. BMC Bioinformatics, 8:180.
17.
De la GrangeP., GratadouL., DelordM., DutertreM., AuboeufD.2010. Splicing factor and exon profiling across human tissues. Nucleic Acids Res., 38:2825–2838.
18.
Den HollanderA.I., HeckenlivelyJ.R., Van den BornL.I., De KokY.J., Van der Velde-VisserS.D., KellnerU., JurkliesB., Van SchooneveldM.J., BlankenagelA., RohrschneiderK., WissingerB., CruysbergJ.R., DeutmanA.F., BrunnerH.G., Apfelstedt-SyllaE., HoyngC.B., CremersF.P.2001. Leber congenital amaurosis and retinitis pigmentosa with Coats-like exudative vasculopathy are associated with mutations in the crumbs homologue 1 (CRB1) gene. Am. J. Hum. Genet., 69:198–203.
19.
Den HollanderA.I., KoenekoopR.K., YzerS., LopezI., ArendsM.L., VoesenekK.E.J., ZonneveldM.N., StromT.M., MeitingerT., BrunnerH.G., HoyngC.B., Van den BornL.I., RohrschneiderK., CremersF.P.M.2006. Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. Am. J. Hum. Genet., 79:556–561.
20.
Den HollanderA.I., KoenekoopR.K., MohamedM.D., ArtsH.H., BoldtK., TownsK.V., SedmakT., BeerM., Nagel-WolfrumK., McKibbinM., DharmarajS., LopezI., IvingsL., WilliamsG.A., SpringellK., WoodsC.G., JafriH., RashidY., StromT.M., Van der ZwaagB., GosensI., KerstenF.F.J., Van WijkE., VeltmanJ.A., ZonneveldM.N., Van BeersumS.E.C., MaumeneeI.H., WolfrumU., CheethamM.E., UeffingM., CremersF.P.M., InglehearnC.F., RoepmanR.2007. Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis. Nat. Genet., 39:889–895.
21.
Den HollanderA.I., RoepmanR., KoenekoopR.K., CremersF.P.M.2008. Leber congenital amaurosis: Genes, proteins and disease mechanisms. Prog. Retin. Eye Res., 27:391–419.
22.
DryjaT.P., AdamsS.M., GrimsbyJ.L., McGeeT.L., HongD.H., LiT., AndréassonS., BersonE.L.2001. Null RPGRIP1 alleles in patients with Leber congenital amaurosis. Am. J. Hum. Genet., 68:1295–1298.
23.
DyerM.A., DonovanS.L., ZhangJ., GrayJ., OrtizA., TenneyR., KongJ., AllikmetsR., SohockiM.M.2004. Retinal degeneration in Aipl1-deficient mice: A new genetic model of Leber congenital amaurosis. Mol. Brain Res., 132:208–220.
24.
EbertA.D., YuJ., RoseF.F.Jr, MattisV.B., LorsonC.L., ThomsonJ.A., SvendsenC.N.2009. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457:277–280.
25.
Estrada-CuzcanoA., KoenekoopR.K., CoppietersF., KohlS., LopezI., CollinR.W.J., De BaereE.B.W., RoeleveldD., MarekJ., BerndA., RohrschneiderK., Van den BornL.I., MeireF., MaumeneeI.H., JacobsonS.G., HoyngC.B., ZrennerE., CremersF.P.M., Den HollanderA.I.2011. IQCB1 mutations in patients with leber congenital amaurosis. Invest. Ophthalmol. Vis. Sci., 52:834–839.
FranceschettiA., DieterleP.1954. [Diagnostic and prognostic importance of the electroretinogram in tapetoretinal degeneration with reduction of the visual field and hemeralopia]Confin. Neurol., 14:184–186.
28.
FreundC.L., WangQ.L., ChenS., MuskatB.L., WilesC.D., SheffieldV.C., JacobsonS.G., McInnesR.R., ZackD.J., StoneE.M.1998. De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis. Nat. Genet., 18:311–312.
29.
FriedmanJ.S., ChangB., KannabiranC., ChakarovaC., SinghH.P., JalaliS., HawesN.L., BranhamK., OthmanM., FilippovaE., ThompsonD.A., WebsterA.R., AndréassonS., JacobsonS.G., BhattacharyaS.S., HeckenlivelyJ.R., SwaroopA.2006. Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration. Am. J. Hum. Genet., 79:1059–1070.
30.
GerberS., PerraultI., HaneinS., BarbetF., DucroqD., GhaziI., Martin-CoignardD., LeowskiC., HomfrayT., DufierJ.L., MunnichA., KaplanJ., RozetJ.M.2001. Complete exon-intron structure of the RPGR-interacting protein (RPGRIP1) gene allows the identification of mutations underlying Leber congenital amaurosis. Eur. J. Hum. Genet., 9:561–571.
31.
GonzálezF., BouéS., Izpisúa BelmonteJ.C.2011. Methods for making induced pluripotent stem cells: Reprogramming à la carte. Nat. Rev. Genet., 12:231–242.
32.
GüvenM., GörgünE., ÜnalM., YenerelM., BatarB., KüçümenB., DinçU.A., GüvenG.S., UlusT., YükselA.2011. Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration. Ophthalmic Res., 46:31–37.
33.
HauswirthW.W., AlemanT.S., KaushalS., CideciyanA.V., SchwartzS.B., WangL., ConlonT.J., BoyeS.L., FlotteT.R., ByrneB.J., JacobsonS.G.2008. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: Short-term results of a phase I trial. Hum. Gene Ther., 19:979–990.
HuangfuD., MaehrR., GuoW., EijkelenboomA., SnitowM., ChenA.E., MeltonD.A.2008a. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol., 26:795–797.
37.
HuangfuD., OsafuneK., MaehrR., GuoW., EijkelenboomA., ChenS., MuhlesteinW., MeltonD.A.2008b. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 26:1269–1275.
38.
JiangZ., LiangK., ZhangQ., TaoL.2012. Glutathione S-transferases polymorphisms confer susceptibility to senile cortical cataract in the Han Chinese population. Mol. Vis., 18:1247–1252.
JordanS.A., FarrarG.J., KennaP., HumphriesM.M., SheilsD.M., Kumar-SinghR., SharpE.M., SorianoN., AyusoC., BenitezJ.1993. Localization of an autosomal dominant retinitis pigmentosa gene to chromosome 7q. Nat. Genet., 4:54–58.
41.
JuronenE., TasaG., VeromannS., PartsL., TiidlaA., PulgesR., PanovA., SoovereL., KokaK., MikelsaarA.V.2000. Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians. Exp. Eye Res., 71:447–452.
42.
KeenT.J., MohamedM.D., McKibbinM., RashidY., JafriH., MaumeneeI.H., InglehearnC.F.2003. Identification of a locus (LCA9) for Leber's congenital amaurosis on chromosome 1p36. Eur. J. Hum. Genet., 11:420–423.
43.
KlimanskayaI., HippJ., RezaiK.A., WestM., AtalaA., LanzaR.2004. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells, 6:217–245.
44.
KoenekoopR.K., WangH., MajewskiJ., WangX., LopezI., RenH., ChenY., LiY., FishmanG.A., GeneadM., SchwartzentruberJ., SolankiN., TraboulsiE.I., ChengJ., LoganC.V., McKibbinM., HaywardB.E., ParryD.A., JohnsonC.A., NageebM., PoulterJ.A., MohamedM.D., JafriH., RashidY., TaylorG.R., KeserV., MardonG., XuH., InglehearnC.F., FuQ., ToomesC., ChenR.2012. Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration. Nat. Genet., 44:1035–1039.
45.
LambaD.A., KarlM.O., WareC.B., RehT.A.2006. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 103:12769–12774.
46.
LeberT.1869. Über retinitis pigmentosa und angeborene amaurose. Albrecht Von Graefes. Arch. Ophthalmol., 15:1–25.
47.
LeeG., PapapetrouE.P., KimH., ChambersS.M., TomishimaM.J., FasanoC.A., GanatY.M., MenonJ., ShimizuF., VialeA., TabarV., SadelainM., StuderL.2009. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature, 461:402–406.
48.
LoteryA.J., JacobsonS.G., FishmanG.A., WeleberR.G., FultonA.B., NamperumalsamyP., HéonE., LevinA.V., GroverS., RosenowJ.R., KoppK.K., SheffieldV.C., StoneE.M.2001. Mutations in the CRB1 gene cause Leber congenital amaurosis. Arch. Ophthalmol., 119:415–420.
49.
MaguireA.M., SimonelliF., PierceE.A., PughE.N.Jr, MingozziF., BennicelliJ., BanfiS., MarshallK.A., TestaF., SuraceE.M., RossiS., LyubarskyA., ArrudaV.R., KonkleB., StoneE., SunJ., JacobsJ., Dell'OssoL., HertleR., MaJ., RedmondT.M., ZhuX., HauckB., ZelenaiaO., ShindlerK.S., MaguireM.G., WrightJ.F., VolpeN.J., McDonnellJ.W., AuricchioA., HighK.A., BennettJ.2008. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med., 358:2240–2248.
MarchettoM.C.N., CarromeuC., AcabA., YuD., YeoG.W., MuY., ChenG., GageF.H., MuotriA.R.2010. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell, 143:527–539.
MatthewsJ.M., SundeM.2002. Zinc fingers—folds for many occasions. IUBMB Life, 54:351–355.
54.
MeyerJ.S., ShearerR.L., CapowskiE.E., WrightL.S., WallaceK.A., McMillanE.L., ZhangS.-C., GammD.M.2009. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA, 106:16698–16703.
55.
MeyerJ.S., HowdenS.E., WallaceK.A., VerhoevenA.D., WrightL.S., CapowskiE.E., PinillaI., MartinJ.M., TianS., StewartR., PattnaikB., ThomsonJ.A., GammD.M.2011. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells, 29:1206–1218.
56.
MoldayR.S., HicksD., MoldayL.1987. Peripherin. A rim-specific membrane protein of rod outer segment discs. Invest. Ophthalmol. Vis. Sci., 28:50–61.
57.
MorimuraH., FishmanG.A., GroverS.A., FultonA.B., BersonE.L., DryjaT.P.1998. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc. Natl. Acad. Sci. USA, 95:3088–3093.
58.
NakanoT., AndoS., TakataN., KawadaM., MugurumaK., SekiguchiK., SaitoK., YonemuraS., EirakuM., SasaiY.2012. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell, 10:771–785.
59.
NapolitanoL.M., MeroniG.2012. TRIM family: Pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life, 64:64–71.
60.
OsakadaF., IkedaH., MandaiM., WatayaT., WatanabeK., YoshimuraN., AkaikeA., AkaikeA., SasaiY., TakahashiM.2008. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat. Biotechnol., 26:215–224.
61.
OthmanH., SaadatI., Farvardin-JahromiM., SaadatM.2012. Susceptibility to exudative age-related macular degeneration and three genetic polymorphisms of glutathione S-transferase Z1 (GSTZ1)Eur. J. Ophthalmol., 22:431–435.
PerraultI., HaneinS., ZanlonghiX., SerreV., NicouleauM., Defoort-DelhemmesS., DelphinN., Fares-TaieL., GerberS., XerriO., EdelsonC., GoldenbergA., DuncombeA., Le MeurG., HamelC., SilvaE., NitschkeP., CalvasP., MunnichA., RocheO., DollfusH., KaplanJ., RozetJ.-M.2012. Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy. Nat. Genet., 44:975–977.
66.
PlafkerS.M., O'MealeyG.B., SzwedaL.I.2012. Mechanisms for countering oxidative stress and damage in retinal pigment epithelium. Int. Rev. Cell Mol. Biol., 298:135–177.
67.
RamamurthyV.2004. From the Cover: Leber congenital amaurosis linked to AIPL1: A mouse model reveals destabilization of cGMP phosphodiesterase. Proc. Natl. Acad. Sci. USA, 101:13897–13902.
68.
RedmondT.M., YuS., LeeE., BokD., HamasakiD., ChenN., GoletzP., MaJ.-X., CrouchR.K., PfeiferK.1998. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet., 20:344–351.
69.
RivoltaC., SharonD., DeAngelisM.M., DryjaT.P.2002. Retinitis pigmentosa and allied diseases: Numerous diseases, genes, and inheritance patterns. Hum. Mol. Genet., 11:1219–1227.
70.
RollingF.2004. Recombinant AAV-mediated gene transfer to the retina: Gene therapy perspectives. Gene Ther., 11,Suppl 1:S26–S32.
71.
SergouniotisP.I., DavidsonA.E., MackayD.S., LiZ., YangX., PlagnolV., MooreA.T., WebsterA.R.2011. Recessive mutations in KCNJ13, encoding an inwardly rectifying potassium channel subunit, cause leber congenital amaurosis. Am. J. Hum. Genet., 89:183–190.
72.
SimonelliF., MaguireA.M., TestaF., PierceE.A., MingozziF., BennicelliJ.L., RossiS., MarshallK., BanfiS., SuraceE.M., SunJ., RedmondT.M., ZhuX., ShindlerK.S., YingG.-S., ZivielloC., AcerraC., WrightJ.F., McDonnellJ.W., HighK.A., BennettJ., AuricchioA.2010. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol. Ther., 18:643–650.
73.
SiuI.-M., BaiR., GalliaG.L., EdwardsJ.B., TylerB.M., EberhartC.G., RigginsG.J.2008. Coexpression of neuronatin splice forms promotes medulloblastoma growth. Neuro-oncology, 10:716–724.
74.
SohockiM.M., BowneS.J., SullivanL.S., BlackshawS., CepkoC.L., PayneA.M., BhattacharyaS.S., KhaliqS., Qasim MehdiS., BirchD.G., HarrisonW.R., ElderF.F., HeckenlivelyJ.R., DaigerS.P.2000. Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis. Nat. Genet., 24:79–83.
StocktonD.W., LewisR.A., AbboudE.B., Al-RajhiA., JabakM., AndersonK.L., LupskiJ.R.1998. A novel locus for Leber congenital amaurosis on chromosome 14q24. Hum. Genet., 103:328–333.
79.
StraussO.2005. The retinal pigment epithelium in visual function. Physiol. Rev., 85:845–881.
80.
TakahashiK., TanabeK., OhnukiM., NaritaM., IchisakaT., TomodaK., YamanakaS.2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
81.
TeichroebJ.H., BettsD.H., VaziriH.2011. Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells. PLoS One, 6:e23436.
82.
ThompsonD.A., LiY., McHenryC.L., CarlsonT.J., DingX., SievingP.A., Apfelstedt-SyllaE., GalA.2001. Mutations in the gene encoding lecithin retinol acyltransferase are associated with early-onset severe retinal dystrophy. Nat. Genet., 28:123–124.
83.
ThomsonJ.A., Itskovitz-EldorJ., ShapiroS.S., WaknitzM.A., SwiergielJ.J., MarshallV.S., JonesJ.M.1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
84.
WangH., Den HollanderA.I., MoayediY., AbulimitiA., LiY., CollinR.W.J., HoyngC.B., LopezI., AbboudE.B., Al-RajhiA.A., BrayM., LewisR.A., LupskiJ.R., MardonG., KoenekoopR.K., ChenR.2009. Mutations in SPATA7 cause Leber congenital amaurosis and juvenile retinitis pigmentosa. Am. J. Hum. Genet., 84:380–387.
85.
WuS.M., HochedlingerK.2011. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol., 13:497–505.
86.
YangR.B., RobinsonS.W., XiongW.H., YauK.W., BirchD.G., GarbersD.L.1999. Disruption of a retinal guanylyl cyclase gene leads to cone-specific dystrophy and paradoxical rod behavior. J. Neurosci., 19:5889–5897.
87.
YokotaN., MainprizeT.G., TaylorM.D., KohataT., LoretoM., UedaS., DuraW., GrajkowskaW., KuoJ.S., RutkaJ.T.2004. Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization. Oncogene, 23:3444–3453.
88.
YoshidaY., YamanakaS.2010. Recent stem cell advances: Induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation, 122:80–87.
89.
ZahabiA., ShahbaziE., AhmadiehH., HassaniS.-N., TotonchiM., TaeiA., MasoudiN., EbrahimiM., AghdamiN., SeifinejadA., MehrnejadF., DaftarianN., SalekdehG.H., BaharvandH.2012. A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells. Stem Cells Dev., 21:2262–2272.
90.
ZeitzC., Kloeckener-GruissemB., ForsterU., KohlS., MagyarI., WissingerB., MátyásG., BorruatF.-X., SchorderetD.F., ZrennerE., MunierF.L., BergerW.2006. Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am. J. Hum. Genet., 79:657–667.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
